5-hydroxydecanoate has been researched along with Insulinoma in 1 studies
5-hydroxydecanoic acid: Potassium Channel Blocker; RN refers to parent cpd
Insulinoma: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaggar, JH | 1 |
| Squires, PE | 1 |
| Dunne, MJ | 1 |
1 other study available for 5-hydroxydecanoate and Insulinoma
| Article | Year |
|---|---|
Effects of 5-hydroxydecanoate on ATP-regulated potassium ion channels in insulin secreting cells.
Topics: Adenosine Triphosphate; Animals; Calcium; Cell Line; Cytosol; Decanoic Acids; Hydroxy Acids; Insulin | 1993 |